Analysis: Stryker Corporation

US:SYK

Why is Stryker Corporation stock rising?

  • Full U.S. commercial launch of Mako RPS handheld robotics expands Stryker's knee robotics offering into ASCs and surgeon segments not ready for full Mako.
  • Triathlon Gold and Triathlon Medial Stabilized Insert knee implants are moving to full commercial launches in 2026.
  • Full commercial launch of the Encompass total ankle replacement system following PROPHECY guide approval.
  • Pangaea Trauma Plating System limited launch in Europe is scheduled to be followed by full commercial launch in Q4 2026.
  • Full commercial launch of Mako shoulder on Mako 4.0 expands the robotic platform into shoulder procedures.

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Stryker Corporation and 4,900+ companies.

Sign in
5-day free pass. No card required.